Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Elliott Bigby, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R29AR039795 (BIGBY, MICHAEL E) Jan 7, 1991 - Dec 31, 1995
    NIH/NIAMS
    T-CELL HYBRIDOMAS TO STUDY CUTANEOUS IMMUNOLOGY
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sladden M, Zagarella S, Popescu C, Bigby M. The sentinel node biopsy has not come of age. Br J Dermatol. 2020 02; 182(2):518. PMID: 31536641.
    Citations:    
  2. Albrecht J, Bigby M. Rifampin and Clindamycin are safe long term Response to North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019 Sep 27. PMID: 31568806.
    Citations:    
  3. Albrecht J, Kramer ON, Bigby M. The recommendations about laboratory monitoring on isotretinoin are reasonable, but the patient numbers cannot prove it. J Am Acad Dermatol. 2019 Apr 09. PMID: 30978425.
    Citations:    
  4. Zagarella S, Bigby M, Sladden M, Popescu C. Letter to the Editor. J Am Acad Dermatol. 2019 Mar 27. PMID: 30928467.
    Citations:    
  5. Albrecht J, Baine PA, Ladizinski B, Jemec GB, Bigby M. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic. Br J Dermatol. 2019 04; 180(4):749-755. PMID: 30281779.
    Citations:    Fields:    
  6. Bigby M, Zagarella S, Sladden M, Popescu CM. Time to reconsider the role of sentinel lymph node biopsy in melanoma. J Am Acad Dermatol. 2019 Apr; 80(4):1168-1171. PMID: 30471314.
    Citations:    Fields:    
  7. Sladden M, Zagarella S, Bigby M. Adjuvant Therapy in Resected Melanoma. N Engl J Med. 2018 02 15; 378(7):678. PMID: 29446283.
    Citations:    Fields:    Translation:Humans
  8. Zagarella SS, Sladden MJ, Popescu CM, Bigby ME. 'Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal' by Omgo E Nieweg, Alan Cooper and John F Thompson. Australas J Dermatol. 2018 05; 59(2):160-161. PMID: 29411864.
    Citations:    Fields:    
  9. Sladden M, Zagarella S, Popescu C, Bigby M. When is a sentinel node biopsy indicated for patients with primary melanoma? Comment on the 'Australian guidelines for the management of cutaneous melanoma'. Australas J Dermatol. 2018 05; 59(2):159-160. PMID: 29411863.
    Citations:    Fields:    
  10. Albrecht J, Mehta S, Bigby M. Development of resistance to Mycobacterium tuberculosis is manageable in hidradenitis suppurativa. Response to 'Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?' Br J Dermatol. 2018 01; 178(1):300. PMID: 28960253.
    Citations:    Fields:    Translation:HumansCells
  11. Opel D, Kramer ON, Chevalier M, Bigby M, Albrecht J. Not every patient needs a triglyceride check, but all can get pancreatitis: a systematic review and clinical characterization of isotretinoin-associated pancreatitis. Br J Dermatol. 2017 Oct; 177(4):960-966. PMID: 27893168.
    Citations:    Fields:    Translation:Humans
  12. Zagarella S, Sladden M, Popescu C, Heenan P, Bigby M. Sentinel node biopsy should not be the standard of care for patients with intermediate and thick melanomas. Aust Fam Physician. 2015 Dec; 44(12):873. PMID: 27505909.
    Citations:    Fields:    Translation:Humans
  13. Bigby M, Popescu C. Sentinel lymph node biopsy in melanoma. BMJ. 2015 Nov 10; 351:h5940. PMID: 26556819.
    Citations:    Fields:    Translation:Humans
  14. Renati S, Cukras A, Bigby M. Pityriasis versicolor. BMJ. 2015 Apr 07; 350:h1394. PMID: 25852089.
    Citations:    Fields:    Translation:HumansAnimals
  15. Sladden M, Zagarella S, Popescu C, Bigby M. No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report. Br J Dermatol. 2015 Mar; 172(3):566-71. PMID: 25776246.
    Citations: 5     Fields:    Translation:Humans
  16. Zagarella SS, Sladden M, Popescu C, Bigby M. Sentinel lymph node biopsy for melanoma: an important risk-stratification tool. Med J Aust. 2015 Feb 02; 202(2):78. PMID: 25627734.
    Citations:    Fields:    Translation:Humans
  17. Maymone MBC, Gan SD, Bigby M. Evaluating the strength of clinical recommendations in the medical literature: GRADE, SORT, and AGREE. J Invest Dermatol. 2014 Oct; 134(10):1-5. PMID: 25219653.
    Citations: 2     Fields:    Translation:Humans
  18. Wu PA, Huang V, Bigby ME. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review. Br J Dermatol. 2014 May; 170(5):1015-20. PMID: 24841586.
    Citations:    Fields:    Translation:Humans
  19. Bigby M. Understanding and Evaluating Systematic Reviews and Meta-analyses. Indian J Dermatol. 2014 Mar; 59(2):134-9. PMID: 24700930.
    Citations:    Fields:    
  20. Nambudiri VE, Bigby ME. Practicing prevention with probiotics. JAMA Dermatol. 2013 Dec; 149(12):1422-4. PMID: 24108541.
    Citations:    Fields:    Translation:HumansCells
  21. Nambudiri VE, Bigby ME. Risk of malignant disease and biologic response modifiers: fact, fiction, and future concerns. JAMA Dermatol. 2013 Oct; 149(10):1221-3. PMID: 23986262.
    Citations: 1     Fields:    Translation:Humans
  22. Popescu CM, Bigby M. The weight of evidence on the association of isotretinoin use and the development of inflammatory bowel disease. JAMA Dermatol. 2013 Feb; 149(2):221-2. PMID: 23426480.
    Citations: 3     Fields:    Translation:Humans
  23. Bigby M. Outcome measures in dermatology: comment on "measurement properties of outcome measures for vitiligo". Arch Dermatol. 2012 Nov; 148(11):1310. PMID: 22986796.
    Citations:    Fields:    
  24. Connolly SM, Baker DR, Coldiron BM, Fazio MJ, Storrs PA, Vidimos AT, Zalla MJ, Brewer JD, Smith Begolka W, Berger TG, Bigby M, Bolognia JL, Brodland DG, Collins S, Cronin TA, Dahl MV, Grant-Kels JM, Hanke CW, Hruza GJ, James WD, Lober CW, McBurney EI, Norton SA, Roenigk RK, Wheeland RG, Wisco OJ. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012 Oct; 67(4):531-50. PMID: 22959232.
    Citations: 32     Fields:    Translation:Humans
  25. Baccaglini L, Thongprasom K, Carrozzo M, Bigby M. Urban legends series: lichen planus. Oral Dis. 2013 Mar; 19(2):128-43. PMID: 22788669.
    Citations: 8     Fields:    Translation:Humans
  26. Ko J, Bigby M. Randomized controlled trial of cryotherapy with liquid nitrogen vs topical salicylic acid vs wait-and-see for cutaneous warts. Arch Dermatol. 2012 Jul; 148(7):840-2. PMID: 22801618.
    Citations:    Fields:    
  27. Bigby M. The use of anti-interleukin-12/23 agents and major adverse cardiovascular events. Arch Dermatol. 2012 Jun; 148(6):753-4. PMID: 22710457.
    Citations:    Fields:    
  28. Gee SN, Bigby M. Atopic dermatitis and attention-deficit/hyperactivity disorder: is there an association? Arch Dermatol. 2011 Aug; 147(8):967-70. PMID: 21844457.
    Citations: 2     Fields:    Translation:Humans
  29. Bigby M, Kim CC. A prospective randomized controlled trial indicates that sunscreen use reduced the risk of developing melanoma. Arch Dermatol. 2011 Jul; 147(7):853-4. PMID: 21768486.
    Citations: 2     Fields:    
  30. Robinson JK, Bigby M. Prevention of melanoma with regular sunscreen use. JAMA. 2011 Jul 20; 306(3):302-3. PMID: 21712528.
    Citations: 3     Fields:    Translation:Humans
  31. Albrecht J, Bigby M. Testing a test: critical appraisal of tests for diagnosing scabies. Arch Dermatol. 2011 Apr; 147(4):494-7. PMID: 21482901.
    Citations: 1     Fields:    Translation:Humans
  32. Bigby M. A randomized controlled trial of the addition of mycophenolate mofetil or placebo to oral corticosteroids in the treatment of pemphigus vulgaris fails to demonstrate a significant difference in the primary outcome or quality of life. Arch Dermatol. 2011 Apr; 147(4):489-91. PMID: 21482899.
    Citations:    Fields:    
  33. Hu SW, Bigby M. Pityriasis versicolor: a systematic review of interventions. Arch Dermatol. 2010 Oct; 146(10):1132-40. PMID: 20956647.
    Citations: 8     Fields:    Translation:Humans
  34. Bigby M. Why the evidence for skin cancer screening is insufficient: lessons from prostate cancer screening. Arch Dermatol. 2010 Mar; 146(3):322-4. PMID: 20231506.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  35. Bigby M. The relationship between lichen planus and hepatitis C clarified. Arch Dermatol. 2009 Sep; 145(9):1048-50. PMID: 19770448.
    Citations: 3     Fields:    Translation:Humans
  36. Albrecht J, Meves A, Bigby M. A survey of case reports and case series of therapeutic interventions in the Archives of Dermatology. Int J Dermatol. 2009 Jun; 48(6):592-7. PMID: 19538367.
    Citations: 4     Fields:    Translation:Humans
  37. Albrecht J, Werth VP, Bigby M. The role of case reports in evidence-based practice, with suggestions for improving their reporting. J Am Acad Dermatol. 2009 Mar; 60(3):412-8. PMID: 19231639.
    Citations: 10     Fields:    Translation:Humans
  38. Hu S, Bigby M. Treating scabies: results from an updated Cochrane review. Arch Dermatol. 2008 Dec; 144(12):1638-40; discussion 1640-1. PMID: 19075150.
    Citations:    Fields:    
  39. Bigby M. Does isotretinoin increase the risk of depression? Arch Dermatol. 2008 Sep; 144(9):1197-9; discussion 1234-5. PMID: 18794466.
    Citations: 3     Fields:    
  40. Robinson JK, Dellavalle RP, Bigby M, Callen JP. Systematic reviews: grading recommendations and evidence quality. Arch Dermatol. 2008 Jan; 144(1):97-9. PMID: 18209174.
    Citations: 4     Fields:    Translation:Humans
  41. Bigby M. Evidence-based dermatology section welcomes a new feature: critically appraised topic. Arch Dermatol. 2007 Sep; 143(9):1185-6. PMID: 17875882.
    Citations:    Fields:    Translation:Humans
  42. Corona R, Bigby M. What are the risks of serious infections and malignancies for patients treated with anti-tumor necrosis factor antibodies? Arch Dermatol. 2007 Mar; 143(3):405-6. PMID: 17372107.
    Citations: 1     Fields:    
  43. Bigby M. Tacrolimus and pimecrolimus for atopic dermatitis: where do they fit in? Arch Dermatol. 2006 Sep; 142(9):1203-5. PMID: 16983008.
    Citations:    Fields:    
  44. Bigby M, Bernhard JD. Proposed policy on identification of race, ethnicity, or skin color in case reports and studies submitted to the Journal of the American Academy of Dermatology. J Am Acad Dermatol. 2006 Jun; 54(6):1077. PMID: 16713473.
    Citations:    Fields:    Translation:Humans
  45. Bigby M, Thaler D. Describing patients' "race" in clinical presentations should be abandoned. J Am Acad Dermatol. 2006 Jun; 54(6):1074-6. PMID: 16713470.
    Citations: 2     Fields:    Translation:Humans
  46. Unaeze J, Bigby M. The frequency of reporting of race/ethnicity in case reports. J Am Acad Dermatol. 2006 Jun; 54(6):1067-70. PMID: 16713465.
    Citations:    Fields:    Translation:Humans
  47. Bigby M, Gibbs S. Warts. Clin Evid. 2005 Dec; (14):2091-103. PMID: 16620484.
    Citations:    Fields:    Translation:Humans
  48. Bigby M. New treatment for atopic dermatitis--facts, comparisons and uncertainties. Ann Acad Med Singapore. 2005 Nov; 34(10):650-1. PMID: 16382254.
    Citations:    Fields:    Translation:Humans
  49. Albrecht J, Meves A, Bigby M. Case reports and case series from Lancet had significant impact on medical literature. J Clin Epidemiol. 2005 Dec; 58(12):1227-32. PMID: 16291466.
    Citations: 21     Fields:    Translation:Humans
  50. Bigby M. Pimecrolimus and tacrolimus for the treatment of intertriginous and facial psoriasis: are they effective? Arch Dermatol. 2005 Sep; 141(9):1152-3. PMID: 16172313.
    Citations: 1     Fields:    
  51. Bigby M, Gibbs S, Harvey I, Sterling J. Warts. Clin Evid. 2004 Jun; (11):2209-23. PMID: 15652108.
    Citations: 3     Fields:    Translation:Humans
  52. Bigby ME. The end of the sunscreen and melanoma controversy? Arch Dermatol. 2004 Jun; 140(6):745-6. PMID: 15210469.
    Citations:    Fields:    Translation:Humans
  53. Bigby M. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis. Arch Dermatol. 2004 Mar; 140(3):347-8. PMID: 15023778.
    Citations:    Fields:    Translation:Humans
  54. Bigby M, Gibbs S, Harvey I, Sterling J. Warts. Clin Evid. 2003 Dec; (10):1925-38. PMID: 15555187.
    Citations:    Fields:    Translation:Humans
  55. Bigby M. Newer antifungal agents. J Am Acad Dermatol. 2003 Aug; 49(2):357; author reply 357-8. PMID: 12894100.
    Citations:    Fields:    Translation:Humans
  56. Bigby M, Williams H. Appraising systematic reviews and meta-analyses. Arch Dermatol. 2003 Jun; 139(6):795-8. PMID: 12810513.
    Citations: 2     Fields:    Translation:Humans
  57. Albrecht J, Bigby M. The meaning of "safe and effective". J Am Acad Dermatol. 2003 Jan; 48(1):144-7. PMID: 12522386.
    Citations:    Fields:    Translation:Humans
  58. Bigby M, Gibbs S, Harvey I, Sterling J. Non-genital warts. Clin Evid. 2002 Dec; (8):1731-44. PMID: 12603967.
    Citations:    Fields:    Translation:Humans
  59. Bigby M, Gibbs S, Harvey I, Sterling J. Non-genital warts. Clin Evid. 2002 Jun; (7):1530-42. PMID: 12230769.
    Citations:    Fields:    Translation:Humans
  60. Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med. 2002; 13(4):350-65. PMID: 12191961.
    Citations: 101     Fields:    Translation:HumansAnimalsCells
  61. Bigby M. The placebo effect: and another one bites the dust. Arch Dermatol. 2001 Dec; 137(12):1639-40. PMID: 11735716.
    Citations:    Fields:    Translation:Humans
  62. Bigby M. A thorough systematic review of treatments for atopic eczema. Arch Dermatol. 2001 Dec; 137(12):1635-6. PMID: 11735714.
    Citations: 1     Fields:    Translation:Humans
  63. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001 Jun; 137(6):765-70. PMID: 11405768.
    Citations: 25     Fields:    Translation:Humans
  64. Bigby M. A population-based estimate of the prevalence of postherpetic neuralgia after herpes zoster. Arch Dermatol. 2001 Jun; 137(6):789-90. PMID: 11405773.
    Citations:    Fields:    Translation:Humans
  65. Tsao H, Nadiminti U, Sober AJ, Bigby M. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. Arch Dermatol. 2001 Mar; 137(3):325-30. PMID: 11255333.
    Citations: 10     Fields:    Translation:HumansCells
  66. Bigby M. Challenges to the hierarchy of evidence: does the emperor have no clothes? Arch Dermatol. 2001 Mar; 137(3):345-6. PMID: 11255336.
    Citations: 1     Fields:    Translation:Humans
  67. Bigby M. Sunscreens, nevi, and melanoma revisited. Arch Dermatol. 2000 Dec; 136(12):1549-50. PMID: 11115170.
    Citations:    Fields:    Translation:Humans
  68. Bigby M. Incidence, prevalence and the rates of cutaneous reactions to drugs. J Eur Acad Dermatol Venereol. 2000 Nov; 14(6):435. PMID: 11444258.
    Citations:    Fields:    Translation:Humans
  69. Liu V, Bigby M. Reactivation of genital herpes simplex virus 2 infection in asymptomatic seropositive persons is frequent. Arch Dermatol. 2000 Sep; 136(9):1141-2. PMID: 10987870.
    Citations: 1     Fields:    Translation:HumansCells
  70. Abeni D, Bigby M, Pasquini P, Szklo M, Williams H. "Evidence-Based Dermatology" section in the archives of dermatology. Arch Dermatol. 2000 Sep; 136(9):1148-9. PMID: 10987874.
    Citations:    Fields:    Translation:Humans
  71. Bigby M. Dermatologic Surgery is an important area of dermatology. Arch Dermatol. 2000 Sep; 136(9):1174. PMID: 10987885.
    Citations:    Fields:    Translation:Humans
  72. Chartier T, Bigby M. Rational follow-up recommendations for patients with melanoma. Arch Dermatol. 2000 Sep; 136(9):1145-7. PMID: 10987873.
    Citations:    Fields:    Translation:Humans
  73. Bigby M. Odds ratios and relative risks. Arch Dermatol. 2000 Jun; 136(6):770-1. PMID: 10871942.
    Citations: 1     Fields:    Translation:Humans
  74. Bigby M. Evidence-based medicine in dermatology. Dermatol Clin. 2000 Apr; 18(2):261-76. PMID: 10791153.
    Citations: 1     Fields:    Translation:Humans
  75. Sugerman PB, Satterwhite K, Bigby M. Autocytotoxic T-cell clones in lichen planus. Br J Dermatol. 2000 Mar; 142(3):449-56. PMID: 10735949.
    Citations: 14     Fields:    Translation:HumansCells
  76. Bigby M. Confidence intervals. Arch Dermatol. 2000 Mar; 136(3):386-7. PMID: 10724202.
    Citations:    Fields:    Translation:Humans
  77. Bigby M. A systematic review of the treatment of scabies. Arch Dermatol. 2000 Mar; 136(3):387-9. PMID: 12102094.
    Citations:    Fields:    
  78. Bigby M. Paradigm lost. Arch Dermatol. 2000 Jan; 136(1):26-7. PMID: 10632182.
    Citations:    Fields:    Translation:Humans
  79. Sugerman PB, Bigby M. Preliminary functional analysis of human epidermal T cells. Arch Dermatol Res. 2000 Jan; 292(1):9-15. PMID: 10664009.
    Citations: 6     Fields:    Translation:HumansCells
  80. Bigby M. The sunscreen and melanoma controversy. Arch Dermatol. 1999 Dec; 135(12):1526-7. PMID: 10606059.
    Citations: 4     Fields:    Translation:Humans
  81. Bigby M. WebDoctor: Your Online Guide to Health Care and Wellness. Arch Dermatol. 1999 Jan 01; 135(1). PMID: 24763393.
    Citations: 1     Fields:    
  82. Bigby M. Snake oil for the 21st century. Arch Dermatol. 1998 Dec; 134(12):1512-4. PMID: 9875187.
    Citations: 1     Fields:    Translation:Humans
  83. Bigby M. Evidence-based medicine in a nutshell. A guide to finding and using the best evidence in caring for patients. Arch Dermatol. 1998 Dec; 134(12):1609-18. PMID: 9875202.
    Citations: 6     Fields:    Translation:Humans
  84. Kane KS, Kwan T, Baden HP, Bigby M. Woman with new-onset boggy scalp. Arch Dermatol. 1998 Apr; 134(4):499-500, 502-3. PMID: 9554305.
    Citations: 1     Fields:    Translation:Humans
  85. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M, Georgopoulos K. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity. 1996 Dec; 5(6):537-49. PMID: 8986714.
    Citations: 161     Fields:    Translation:AnimalsCells
  86. Bigby M. Ruling out the diagnosis. Arch Dermatol. 1996 Jun; 132(6):697-8. PMID: 8651722.
    Citations:    Fields:    Translation:Humans
  87. Bigby M, Gadenne AS. Understanding and evaluating clinical trials. J Am Acad Dermatol. 1996 Apr; 34(4):555-90; quiz 591-3. PMID: 8601646.
    Citations: 3     Fields:    Translation:Humans
  88. Ma J, Wang JH, Guo YJ, Sy MS, Bigby M. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol. 1994 Oct 15; 158(2):389-99. PMID: 7923390.
    Citations: 12     Fields:    Translation:AnimalsCells
  89. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 1994 Oct 07; 79(1):143-56. PMID: 7923373.
    Citations: 217     Fields:    Translation:AnimalsCells
  90. Gadenne AS, Strucke R, Dunn D, Wagner M, Bleicher P, Bigby M. T-cell lines derived from lesional skin of lichen planus patients contain a distinctive population of T-cell receptor gamma delta-bearing cells. J Invest Dermatol. 1994 Sep; 103(3):347-51. PMID: 8077699.
    Citations:    Fields:    Translation:HumansCells
  91. Ma J, Wang JH, Sy MS, Guo YJ, Hauser C, Bigby M. Trinitrophenol reactive T-cell hybridomas recognize antigens that require antigen processing. J Invest Dermatol. 1994 Jul; 103(1):42-8. PMID: 8027580.
    Citations:    Fields:    Translation:AnimalsCells
  92. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy MS. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 1994 Mar 15; 54(6):1561-5. PMID: 7511044.
    Citations: 45     Fields:    Translation:HumansAnimalsCells
  93. Guo YJ, Lin SC, Wang JH, Bigby M, Sy MS. Palmitoylation of CD44 interferes with CD3-mediated signaling in human T lymphocytes. Int Immunol. 1994 Feb; 6(2):213-21. PMID: 7512372.
    Citations: 8     Fields:    Translation:HumansCells
  94. Guo YJ, Ma J, Wong JH, Lin SC, Chang HC, Bigby M, Sy MS. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Cell Immunol. 1993 Nov; 152(1):186-99. PMID: 7694807.
    Citations: 8     Fields:    Translation:HumansAnimalsCells
  95. Bigby M, Markowitz JS, Bleicher PA, Grusby MJ, Simha S, Siebrecht M, Wagner M, Nagler-Anderson C, Glimcher LH. Most gamma delta T cells develop normally in the absence of MHC class II molecules. J Immunol. 1993 Nov 01; 151(9):4465-75. PMID: 8409413.
    Citations: 14     Fields:    Translation:AnimalsCells
  96. Dunn DA, Gadenne AS, Simha S, Lerner EA, Bigby M, Bleicher PA. T-cell receptor V beta expression in normal human skin. Proc Natl Acad Sci U S A. 1993 Feb 15; 90(4):1267-71. PMID: 7679496.
    Citations: 10     Fields:    Translation:HumansCells
  97. Phillips TJ, Bigby M, Bercovitch L. Cultured allografts as an adjunct to the medical treatment of problematic leg ulcers. Arch Dermatol. 1991 Jun; 127(6):799-801. PMID: 2036026.
    Citations:    Fields:    Translation:Humans
  98. Baden LA, Bigby M, Kwan T. Persistent necrotic digits in a patient with the acquired immunodeficiency syndrome. Herpes simplex virus infection. Arch Dermatol. 1991 Jan; 127(1):113, 116. PMID: 1986693.
    Citations:    Fields:    Translation:Humans
  99. Bigby M, Wang P, Fierro JF, Sy MS. Phorbol myristate acetate-induced down-modulation of CD4 is dependent on calmodulin and intracellular calcium. J Immunol. 1990 Apr 15; 144(8):3111-6. PMID: 2109010.
    Citations: 5     Fields:    Translation:AnimalsCells
  100. Bigby M, Vargas R, Sy MS. Production of hapten-specific T cell hybridomas and their use to study the effect of ultraviolet B irradiation on the development of contact hypersensitivity. J Immunol. 1989 Dec 15; 143(12):3867-72. PMID: 2480375.
    Citations: 4     Fields:    Translation:AnimalsCells
  101. Bigby M, Stern RS, Arndt KA. Allergic cutaneous reactions to drugs. Prim Care. 1989 Sep; 16(3):713-27. PMID: 2529577.
    Citations: 1     Fields:    Translation:Humans
  102. Bigby M. Nonsteroidal anti-inflammatory drug reactions. Semin Dermatol. 1989 Sep; 8(3):182-6. PMID: 2534881.
    Citations:    Fields:    Translation:Humans
  103. Sleckman BP, Bigby M, Greenstein JL, Burakoff SJ, Sy MS. Requirements for modulation of the CD4 molecule in response to phorbol myristate acetate. Role of the cytoplasmic domain. J Immunol. 1989 Mar 01; 142(5):1457-62. PMID: 2783943.
    Citations: 10     Fields:    Translation:AnimalsCells
  104. Bigby M, Stern RS. Adverse reactions to isotretinoin. A report from the Adverse Drug Reaction Reporting System. J Am Acad Dermatol. 1988 Mar; 18(3):543-52. PMID: 3280622.
    Citations: 15     Fields:    Translation:Humans
  105. Bigby M, McCoy K. Reddish-blue hands and feet. Acrocyanosis with atrophy. Arch Dermatol. 1988 Feb; 124(2):265, 268. PMID: 3341810.
    Citations:    Fields:    Translation:Humans
  106. Bigby M, Kwan T, Sy MS. Ratio of Langerhans cells to Thy-1+ dendritic epidermal cells in murine epidermis influences the intensity of contact hypersensitivity. J Invest Dermatol. 1987 Nov; 89(5):495-9. PMID: 2889783.
    Citations: 9     Fields:    Translation:AnimalsCells
  107. Wang PT, Bigby M, Sy MS. Selective down modulation of L3T4 molecules on murine thymocytes by the tumor promoter, phorbol 12-myristate 13-acetate. J Immunol. 1987 Oct 01; 139(7):2157-65. PMID: 3498751.
    Citations: 3     Fields:    Translation:AnimalsCells
  108. Bigby M, Jick S, Jick H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA. 1986 Dec 26; 256(24):3358-63. PMID: 2946876.
    Citations: 46     Fields:    Translation:Humans
  109. Bigby M, Stern RS, Bigby JA. An evaluation of method reporting and use in clinical trials in dermatology. Arch Dermatol. 1985 Nov; 121(11):1394-9. PMID: 4051526.
    Citations: 3     Fields:    Translation:Humans
  110. Bigby M, Stern R. Cutaneous reactions to nonsteroidal anti-inflammatory drugs. A review. J Am Acad Dermatol. 1985 May; 12(5 Pt 1):866-76. PMID: 3159761.
    Citations: 7     Fields:    Translation:Humans
  111. Stern RS, Bigby M. An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs. JAMA. 1984 Sep 21; 252(11):1433-7. PMID: 6236306.
    Citations: 12     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Bigby's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (367)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.